131 related articles for article (PubMed ID: 10917479)
1. Sentinel lymph node biopsy in breast cancer.
Sakorafas GH; Tsiotou AG
Am Surg; 2000 Jul; 66(7):667-74. PubMed ID: 10917479
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node mapping in breast cancer.
Cody HS
Oncology (Williston Park); 1999 Jan; 13(1):25-34; discussion 35-6, 39, 43. PubMed ID: 10027197
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node biopsy in early breast cancer: the first 100 cases performed in a teaching institute.
Mahajna A; Hershko DD; Israelit S; Abu-Salih A; Keidar Z; Krausz MM
Isr Med Assoc J; 2003 Aug; 5(8):556-9. PubMed ID: 12929292
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
6. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer.
Jansen L; Doting MH; Rutgers EJ; de Vries J; Olmos RA; Nieweg OE
Br J Surg; 2000 Jul; 87(7):920-5. PubMed ID: 10931029
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
Nwariaku FE; Euhus DM; Beitsch PD; Clifford E; Erdman W; Mathews D; Albores-Saavedra J; Leitch MA; Peters GN
Am J Surg; 1998 Dec; 176(6):529-31. PubMed ID: 9926784
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma.
Czerniecki BJ; Scheff AM; Callans LS; Spitz FR; Bedrosian I; Conant EF; Orel SG; Berlin J; Helsabeck C; Fraker DL; Reynolds C
Cancer; 1999 Mar; 85(5):1098-103. PubMed ID: 10091794
[TBL] [Abstract][Full Text] [Related]
9. Final results of the Department of Defense multicenter breast lymphatic mapping trial.
Shivers S; Cox C; Leight G; Beauchamp D; Blumencranz P; Ross M; Reintgen D
Ann Surg Oncol; 2002 Apr; 9(3):248-55. PubMed ID: 11923131
[TBL] [Abstract][Full Text] [Related]
10. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
11. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
12. [Sentinel lymph node biopsy and low axillary node sampling for breast cancer].
Sawai K; Nakajima H; Ohe S; Mizuta N; Sakaguchi K; Hachimine Y
Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):825-30. PubMed ID: 12478860
[TBL] [Abstract][Full Text] [Related]
13. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
14. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
15. Causes of false-negative sentinel node biopsy in patients with breast cancer.
Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
Br J Surg; 2013 May; 100(6):775-83. PubMed ID: 23436699
[TBL] [Abstract][Full Text] [Related]
16. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
17. Is axillary reverse mapping feasible in breast cancer patients?
Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
[TBL] [Abstract][Full Text] [Related]
18. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B
Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648
[TBL] [Abstract][Full Text] [Related]
19. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel lymph node biopsy and axillary lymph node dissection].
Noguchi M; Tsugawa K; Miwa K; Taniya T
Gan To Kagaku Ryoho; 2000 Jul; 27(7):961-6. PubMed ID: 10925679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
